• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·WORX
Share

SCWorx Corp. Stocks

$ 1.96Last Updated 15.10.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 40.80M

$ 1.96
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States. The company delivers a broad spectrum of data-focused services, encompassing the repair, standardization, and interoperability of healthcare information for providers, alongside delivering sophisticated big data analytics for the sector. Its diverse offerings include virtualized item master file repair, expansion, and automation; management of electronic medical records (EMR) and charge description masters (CDM); optimization of contract management; automation of request for proposal (RFP) and rebate processes; integration of acquired management systems; big data analytics modeling; data integration and warehousing; and its proprietary ScanWorx solution. Beyond its core healthcare IT endeavors, SCWorx has diversified into other areas. It operates CageTix, an online event ticketing platform specifically targeting regional mixed martial arts events. Additionally, the company is involved in the provision of personal protective equipment (PPE) and rapid COVID-19 test kits. SCWorx distributes its specialized solutions and services to hospitals and health systems through a multi-channel approach, leveraging both its internal sales team and strategic distribution and reseller partnerships.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 08:00

Pharmaceutical companies benefited from the sell-off in the AI sector. Which stocks are nearing their all-time highs?

16.10.2026 03:35

Tesla is preparing to unveil its "flying" Roadster electric car. Its release has been delayed for nine years.

16.10.2026 03:08

Investors weigh lower Anthropic IPO valuation after $2 trln expectations

16.10.2026 02:18

Vote of confidence: Apple and Meta team up to bring new Muse AI model to Macs

16.10.2026 01:18

Nasdaq stages biggest intraday comeback since April; CoreWeave rebounds 6%

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026